Offer - Urjas Oil for just ₹ 1
Sefdin LB Tablet (6) is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Is the use of Sefdin LB Tablet (6) safe for pregnant women?
Pregnant women can take Sefdin without worrying about any side effects.
Is the use of Sefdin LB Tablet (6) safe during breastfeeding?
Sefdin is safe for breastfeeding women.
What is the effect of Sefdin LB Tablet (6) on the Kidneys?
Sefdin has very mild side effects on the kidneys.
What is the effect of Sefdin LB Tablet (6) on the Liver?
Sefdin is completely safe for the liver.
What is the effect of Sefdin LB Tablet (6) on the Heart?
Using Sefdin does not have any harmful effects on the heart.
If you are suffering from any of the following diseases, you should not take Sefdin LB Tablet (6) unless your doctor advises you to do so -
Is this Sefdin LB Tablet (6) habit forming or addictive?
Sefdin LB Tablet (6) is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Sefdin LB Tablet (6). So it is best to avoid driving.
Is it safe?
Yes, but consume Sefdin LB Tablet (6) only on doctor's advice.
Is it able to treat mental disorders?
No, Sefdin LB Tablet (6) is not used to treat mental disorders.
Interaction between Food and Sefdin LB Tablet (6)
Sefdin LB Tablet (6) may take longer to act if you eat some foods while taking it. Follow your doctor's advice on this.
Interaction between Alcohol and Sefdin LB Tablet (6)
It is difficult to say anything about the effect of Sefdin LB Tablet (6) and alcohol. No research has been done on this yet.
This medicine data has been created by -
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 307-310
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 728
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Omnicef® (cefdinir)